Advances in the treatment of Hodgkin lymphoma.

@article{Eichenauer2012AdvancesIT,
  title={Advances in the treatment of Hodgkin lymphoma.},
  author={Dennis A. Eichenauer and Andreas Engert},
  journal={International journal of hematology},
  year={2012},
  volume={96 5},
  pages={535-43}
}
In the past decades, Hodgkin lymphoma (HL) has turned from an incurable disease to one with the most favorable prognosis among adult malignancies. This is due to the introduction of effective multi-agent chemotherapy and the optimization of radiation techniques. At present, 80-90 % of patients achieve long-term remission when receiving appropriate first-line treatment. Even in case of relapse, up to 50 % can be successfully salvaged with high-dose chemotherapy and autologous stem cell… CONTINUE READING